Han S - Search Results

1

LINC00982 Inhibits the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-765/DPF3 Axis.

Chi F, Qiu F, Jin X, Chen L, He G, Han S. Chi F, et al. Among authors: han s. DNA Cell Biol. 2022 Apr;41(4):424-436. doi: 10.1089/dna.2021.0866. Epub 2022 Mar 21. DNA Cell Biol. 2022. PMID: 35325570

2

The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway.

Han S, Jin X, Liu Z, Xing F, Han Y, Yu X, He G, Qiu F. Han S, et al. Among authors: han y. Biochem Cell Biol. 2019 Oct;97(5):655-664. doi: 10.1139/bcb-2018-0313. Epub 2019 Jan 24. Biochem Cell Biol. 2019. PMID: 30676763

3

Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.

Han S, Qiu F, Han Y, Xu Y, Yin J, Xing F, Bian X, He G. Han S, et al. Among authors: han y. J Appl Clin Med Phys. 2021 Jan;22(1):293-298. doi: 10.1002/acm2.13122. Epub 2020 Dec 17. J Appl Clin Med Phys. 2021. PMID: 33332730 Free PMC article.

4

CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.

Chi F, Chen L, Jin X, He G, Liu Z, Han S. Chi F, et al. Among authors: han s. Exp Cell Res. 2022 Mar 15;412(2):113035. doi: 10.1016/j.yexcr.2022.113035. Epub 2022 Jan 21. Exp Cell Res. 2022. PMID: 35065924

5

SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer.

Chen L, Han S, Li Y, Zheng Y, Zhang Q. Chen L, et al. Among authors: han s. Exp Cell Res. 2022 Aug 1;417(1):113194. doi: 10.1016/j.yexcr.2022.113194. Epub 2022 May 4. Exp Cell Res. 2022. PMID: 35523305

6

TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-κB pathway.

Chi F, Jin X, Chen L, He G, Han S. Chi F, et al. Among authors: han s. Mol Cell Biochem. 2022 Dec;477(12):2801-2816. doi: 10.1007/s11010-022-04480-7. Epub 2022 Jun 1. Mol Cell Biochem. 2022. PMID: 35648115

7

LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway.

Han S, Jin X, Hu T, Chi F. Han S, et al. Oncol Rep. 2023 Mar;49(3):60. doi: 10.3892/or.2023.8497. Epub 2023 Feb 17. Oncol Rep. 2023. PMID: 36799186 Free PMC article.

8

ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop.

Han S, Jin X, Hu T, Chi F. Han S, et al. Carcinogenesis. 2023 Aug 10;44(5):369-382. doi: 10.1093/carcin/bgad042. Carcinogenesis. 2023. PMID: 37326327

9

The mRNA stability of NCAPG2, a novel contributor to breast invasive carcinoma, is enhanced by the RNA-binding protein PCBP2.

Han S, Jin X, Hu T, Chi F. Han S, et al. Cell Signal. 2023 Oct;110:110844. doi: 10.1016/j.cellsig.2023.110844. Epub 2023 Aug 6. Cell Signal. 2023. PMID: 37544634

10

Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.

Gu X, Xue JQ, Han SJ, Qian SY, Zhang WH. Gu X, et al. Cancer Biomark. 2016;16(3):395-403. doi: 10.3233/CBM-160578. Cancer Biomark. 2016. PMID: 27062696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,473 results

Search Page

Filters